← Back to Search

Self-Compassion Intervention Arm for Depression (SCOPE Trial)

N/A
Waitlist Available
Led By Shadi Beshai, PhD
Research Sponsored by University of Regina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
To be eligible to participate in the study, participants must be: a) 18 years old or older; b) have experienced at least one episode of depression; and c) exhibit elevated residual symptoms of depression-as indicated by a score of 5 or more on the Patient Health Questionnaire-9 (PHQ-9; Kroenke, Spitzer, & Williams, 2001). As the majority of people experience both depression and anxiety symptoms concurrently, participants experiencing elevated anxiety symptoms will not be excluded from the study.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-intervention, 3, 6, 9, and 12 months
Awards & highlights

SCOPE Trial Summary

This trial is examining whether a self-compassion intervention is effective in preventing relapse/recurrence of depression over a 12-month period.

Eligible Conditions
  • Depression

SCOPE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

SCOPE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-intervention, 3, 6, 9, and 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and post-intervention, 3, 6, 9, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Longitudinal Interval Follow-UP Evaluation - Structured Clinical Interview (LIFE-SCID)
Scores on the Patient Health Questionnaire - 9 over 12-months
Weeks to Relapse
Secondary outcome measures
Experiences Questionnaire-Decentering
Fears of Compassion Scales (FCS)
Five-Facet Mindfulness Questionnaire-15
+1 more

SCOPE Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Self-Compassion Intervention ArmExperimental Treatment1 Intervention
Participants randomized to this condition will receive access to the audio Mindful Self-Compassion self-help intervention. The intervention is 7 weeks in duration (with a pacing of one lesson per week) and participants are asked to complete study measures once each week of the intervention.
Group II: Self-ReflectionActive Control1 Intervention
Participants randomized to this active control condition will be asked to complete study measures at the same assessment intervals as those in the experimental arm. In addition to completing the measures, participants in the Self-Reflection Active Control condition will be asked to reflect on their self-reported symptoms and changes they may have experienced between assessment intervals.

Find a Location

Who is running the clinical trial?

University of ReginaLead Sponsor
48 Previous Clinical Trials
8,396 Total Patients Enrolled
21 Trials studying Depression
3,979 Patients Enrolled for Depression
University of AmsterdamOTHER
40 Previous Clinical Trials
23,898 Total Patients Enrolled
3 Trials studying Depression
225 Patients Enrolled for Depression
University of OxfordOTHER
1,054 Previous Clinical Trials
16,203,443 Total Patients Enrolled
44 Trials studying Depression
11,694 Patients Enrolled for Depression

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~24 spots leftby Apr 2025